• 
  Ingrid Masson, Laurène Larriviere, Marc-André Mahé, David Azria, Pascal Pommier, et al.. Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer. Clinical and Translational Radiation Oncology, 2024, 44, pp.100702. ⟨10.1016/j.ctro.2023.100702⟩. ⟨hal-04813716⟩
• 
  Jennifer Le Guévelou, Thomas Zilli, Ludovic Ferretti, Luc Beuzit, Olivier de Hertogh, et al.. Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy : Contouring Guidelines on Behalf of the Francophone Group of Urological Radiation Therapy. Practical Radiation Oncology: An official journal of the American Society for Radiation Oncology, 2024, 14 (6), pp.541-554. ⟨10.1016/j.prro.2024.05.009⟩. ⟨hal-04812312⟩
• 
  Sylvain Manfredi, Anthony Turpin, David Malka, Emilie Barbier, Pierre Laurent-Puig, et al.. Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III study. Digestive and Liver Disease, 2020, 52 (10), pp.1143-1147. ⟨10.1016/j.dld.2020.06.034⟩. ⟨hal-04548048⟩
• 
  Sarah Atallah, Odile Casiraghi, Nicolas Fakhry, Michel Wassef, Emmanuelle Uro-Coste, et al.. A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors. European journal of cancer, 2020, 130, pp.241-249. ⟨10.1016/j.ejca.2020.01.023⟩. ⟨hal-03599053⟩
• 
  Isis Carton, Estelle Le Pabic, Alexandre Thobie, Heithem Jeddou, Fabien Robin, et al.. Impact of late-night liver transplantation on recipient outcome. Updates in Surgery, 2024, 76 (7), pp.2635-2643. ⟨10.1007/s13304-024-01991-4⟩. ⟨hal-04765894⟩
• 
  Cassandra Parent, Elodie Lespagnol, Serge Berthoin, Sémah Tagougui, Joris Heyman, et al.. Les freins à l’activité physique chez les enfants et adultes avec un diabète de type 1 : Quels liens réels avec les excursions glycémiques lors de l’activité physique ?. SFD 2022, Mar 2022, Nice, France. ⟨hal-04803477⟩
• 
  Bérengère Kozon, Pierre Fontaine, Anne Vambergue, Marie‐christine Vantyghem, Wassila Ribero-Karrouz, et al.. Vivre avec un diabète de type 1 : L’impact de la préparation de sa consultation diabétologique sur son sentiment d’auto-efficacité personnelle. SFD 2023, Mar 2023, Montpellier, France. ⟨hal-04803413⟩
• 
  Loig Vaugier, Elvire Martin-Mervoyer, Loic Ah-Thiane, Martin Langé, Luc Ollivier, et al.. How to contour the different heart subregions for future deep-learning modeling of the heart: A practical pictorial proposal for radiation oncologists. Clinical and Translational Radiation Oncology, 2024, 45, pp.100718. ⟨10.1016/j.ctro.2023.100718⟩. ⟨hal-04791592⟩
• 
  Julien Leenhardt, Luc Choisnard, Maelle Plasse, Valérie Ardisson, Nicolas de Leiris, et al.. Bacterial survival in radiopharmaceutical solutions: a critical impact on current practices. European Association of Nuclear Medicine, issuing body - EJNMMI radiopharmacy and chemistry, 2023, 8 (1), pp.34. ⟨10.1186/s41181-023-00221-3⟩. ⟨hal-04777250⟩
• 
  Jesus M Eraso, Randall J Olsen, S Wesley Long, Ryan Gadd, Sarrah Boukthir, et al.. Integrative genomic, virulence, and transcriptomic analysis of emergent Streptococcus dysgalactiae subspecies equisimilis (SDSE) emm type stG62647 isolates causing human infections. mBio, 2024, pp.e0257824. ⟨10.1128/mbio.02578-24⟩. ⟨hal-04765930⟩
• 
  Rayan Kabirian, Maria Alice Franzoi, Julie Havas, Charles Coutant, Olivier Trédan, et al.. Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer. JAMA Network Open, 2023, 6 (11), pp.e2343910. ⟨10.1001/jamanetworkopen.2023.43910⟩. ⟨hal-04765786⟩
• 
  Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, et al.. Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nature Medicine, 2023, 29 (10), pp.2665-2665. ⟨10.1038/s41591-023-02624-w⟩. ⟨hal-04755672⟩
• 
  Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, et al.. Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nature Medicine, 2024, 30 (7), pp.2089 - 2089. ⟨10.1038/s41591-024-03053-z⟩. ⟨hal-04753011⟩
• 
  Olivier Coux, Rosa Farràs, Abbas Mohamad, Barrio Rosa, Blattner Christine, et al.. ProteoCure : A European network to fine-tune the proteome. Biochimie, 2024, 226, pp.4-9. ⟨10.1016/j.biochi.2024.06.004⟩. ⟨hal-04737518⟩
• 
  Marie-Pierre Bonnet, Perrine Guckert, Cécile Boccara, Chafia Daoui, Hélène Beloeil. New set of indicators with consensus definition for anaesthesia-related severe morbidity: A scoping review followed by a Delphi study. Journal of Clinical Anesthesia, 2024, 99, pp.111626. ⟨10.1016/j.jclinane.2024.111626⟩. ⟨hal-04719981v2⟩
• 
  Raphaël Pineau, Pierre Jean Le Reste, Tony Avril, Ulrich Jarry, Eric Chevet, et al.. Protocol to generate two distinct standard-of-care murine glioblastoma models for evaluating novel combination therapies. STAR Protocols, 2024, 5 (3), pp.103304. ⟨10.1016/j.xpro.2024.103304⟩. ⟨hal-04719892⟩
• 
  Clémence Pierre, Yannick Le Guen, Caroline Giordanengo, Thomas Goter, Hervé Léna, et al.. Safety and efficacy of immunotherapy using a double-dose regimen in advanced non-small cell lung cancer (NSCLC): results of IDEE study. Translational Lung Cancer Research, 2024, 13 (8), pp.1807-1815. ⟨10.21037/tlcr-24-141⟩. ⟨hal-04719854v2⟩
• 
  Marcela Carausu, Matthieu Carton, Luc Cabel, Anne Patsouris, Christelle Levy, et al.. Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database. Therapeutic Advances in Medical Oncology, 2022, 14, pp.175883592210770. ⟨10.1177/17588359221077082⟩. ⟨hal-03867853⟩
• 
  Panagiotis Papoutsoglou, Raphaël Pineau, Raffaele Leroux, Corentin Louis, Anais l'Haridon, et al.. TGFβ-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma. EMBO Reports, 2024, 25 (3), pp.1022-1054. ⟨10.1038/s44319-024-00075-z⟩. ⟨hal-04615801⟩
• 
  Vincent Hautefeuille, Nicolas Williet, Anthony Turpin, Bertrand Napoleon, Aurélien Dupré, et al.. Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR). Digestive and Liver Disease, 2024, 56 (9), pp.1452-1460. ⟨10.1016/j.dld.2024.04.027⟩. ⟨hal-04603000⟩

740

737